XML 47 R32.htm IDEA: XBRL DOCUMENT v3.21.1
Organization - Additional Information (Details) - USD ($)
3 Months Ended 12 Months Ended
Aug. 03, 2020
Jul. 22, 2020
Jun. 22, 2020
Jun. 01, 2020
May 28, 2019
Mar. 22, 2021
Dec. 31, 2020
Dec. 31, 2019
Subsidiary Sale Of Stock [Line Items]                
Proceeds from issuance of common stock upon public offering, net of issuance costs             $ 100,664,000 $ 50,321,000
Accumulated deficit             126,986,000 $ 92,491,000
Cash, cash equivalents and marketable securities             $ 283,600,000  
Common Stock                
Subsidiary Sale Of Stock [Line Items]                
Conversion of redeemable convertible preferred stock into common stock, shares               13,139,794
IPO                
Subsidiary Sale Of Stock [Line Items]                
Issuance of common stock, net of issuance costs, shares         5,750,000      
Common stock, price per share         $ 10.00      
Conversion of redeemable convertible preferred stock into common stock, shares         13,139,794      
Proceeds from issuance of common stock in initial public offering, net of issuance costs         $ 50,200,000      
Underwriting discounts and commissions         4,000,000      
Offering costs         $ 3,300,000      
IPO | Common Stock                
Subsidiary Sale Of Stock [Line Items]                
Issuance of common stock, net of issuance costs, shares               5,750,000
Overallotment Option                
Subsidiary Sale Of Stock [Line Items]                
Issuance of common stock, net of issuance costs, shares         750,000      
Follow-on Public Offering                
Subsidiary Sale Of Stock [Line Items]                
Issuance of common stock, net of issuance costs, shares   500,000 6,666,667          
Common stock price per share     $ 15.00          
Gross proceeds from issuance common stock   $ 7,500,000 $ 100,000,000          
Proceeds from issuance of common stock upon public offering, net of issuance costs   $ 100,700,000            
Follow-on Public Offering | Common Stock                
Subsidiary Sale Of Stock [Line Items]                
Issuance of common stock, net of issuance costs, shares             7,166,667  
Private Placement | Common Stock                
Subsidiary Sale Of Stock [Line Items]                
Issuance of common stock, net of issuance costs, shares             1,333,333  
Private Placement | Glaxo Group Limited                
Subsidiary Sale Of Stock [Line Items]                
Issuance of common stock, net of issuance costs, shares 1,333,333              
Common stock price per share $ 15.00              
Proceeds from issuance of common stock upon public offering, net of issuance costs $ 20,000,000              
At The Market Offering | Subsequent Event                
Subsidiary Sale Of Stock [Line Items]                
Issuance of common stock, net of issuance costs, shares           2,709,385    
Proceeds from issuance of common stock upon public offering, net of issuance costs           $ 43,300,000    
At The Market Offering | Common Stock                
Subsidiary Sale Of Stock [Line Items]                
Issuance of common stock, net of issuance costs, shares             410,896  
At The Market Offering | Jefferies LLC | Common Stock                
Subsidiary Sale Of Stock [Line Items]                
Issuance of common stock, net of issuance costs, shares             410,896  
Proceeds from issuance of common stock upon public offering, net of issuance costs             $ 6,600,000  
At The Market Offering | Jefferies LLC | Common Stock | Subsequent Event                
Subsidiary Sale Of Stock [Line Items]                
Issuance of common stock, net of issuance costs, shares           2,709,385    
Proceeds from issuance of common stock upon public offering, net of issuance costs           $ 43,300,000    
At The Market Offering | Jefferies LLC | Common Stock | Maximum                
Subsidiary Sale Of Stock [Line Items]                
Sale of common stock aggregate offering price       $ 50,000,000